Automated Analysis Device for Cell Culture Environment 'BioProfile FLEX2'
BioProfile FLEX2
Accelerating the development of the COVID-19 vaccine - Rapid simultaneous measurement of multiple items with trace samples using the automatic analysis device for cell culture environments, FLEX2.
To prevent the spread of the novel coronavirus (COVID-19), the urgent development of vaccines is required. It is said that managing the culture environment is crucial in the process of vaccine research and development involving host cell cultures. The "BioProfile" series of cell culture environment analysis devices from Nova Biomedical is widely adopted by major pharmaceutical companies and institutions in Japan and around the world for managing culture environments in vaccine research, development, and manufacturing processes. At Nova Biomedical, we hope to contribute, albeit modestly, to the development of COVID-19 vaccines by offering flexible purchasing programs tailored to your budget. For more details, please contact us through the inquiry form, and we will respond promptly. We also have materials available for cell culture analysis using our devices. 【Features】 - Monitoring the progress of cell culture - Quantification of key components in the culture medium - Early detection of abnormalities in the culture environment through regular monitoring - Capability to measure multiple items with one device, significantly reducing measurement time by consolidating the functions of multiple devices into one - Numerical backing for the timing of medium changes - Maintenance-free and sensor card-based, reducing the workload for researchers on equipment maintenance
Inquire About This Product
basic information
The "BioProfile FLEX2" is an analytical device that employs micro-sensor technology. This technology allows the "BioProfile FLEX2" to achieve "reduced maintenance related to electrodes," "shortened measurement time," and "significantly reduced sample volume," making it an automated analysis device for cell culture environments. It can measure all 16 parameters with a minimal sample volume. All 16 parameters can be measured in just 4 minutes and 30 seconds, and with individual modules, the measurement is completed in 2 minutes. 【Measurement Items】Up to 16 items Metabolites: Gluc, Lac, Gln, Glu Electrolytes: NH4+, Na+, K+, Ca++ Gases: pH, PCO2, PO2 Total cell density, viable cell density, viability, cell diameter, osmotic pressure 【Specifications】 ■Automatic calibration: 2 hours (fixed) / Required time 2 minutes ■Operating environment: Temperature 10~30℃, Humidity 20~85% ■External dimensions: Width 432 × Depth 635 × Height 610 mm Width 640 × Depth 635 × Height 610 mm (with osmotic pressure module) ■Power supply: AC90–534V, 50/60Hz ■Weight: 42.6 kg (main unit) 65.9 kg (with osmotic pressure module)
Price information
It depends on the module.
Delivery Time
Applications/Examples of results
【Application Examples】 ■ Non-invasive measurement of cell proliferation from glucose consumption and lactate production ■ Optimization of layered culture conditions based on glucose consumption and ammonia production ■ Removal of undifferentiated stem cells and purification of tissue-differentiated cells through medium component adjustment ■ Role of iPS cell survival and glutamine metabolism *For more details, please refer to the PDF document or feel free to contact us.
catalog（9）
Download All Catalogs![[Verification Material] Study on Quality Control through Parameter Measurement in iPS Cell Culture Supernatant](https://image.mono.ipros.com/public/catalog/image/01/60f/493367/IPROS23718073658714076613.jpeg?w=120&h=170)
![[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation](https://image.mono.ipros.com/public/catalog/image/01/38c/440458/IPROS56142213031488853103.jpeg?w=120&h=170)
![[Product Specifications] Automatic Analysis Device for Cell Culture Environment 'BioProfile FLEX2'](https://image.mono.ipros.com/public/catalog/image/01/2d4/423790/IPROS10785152400559635376.jpeg?w=120&h=170)
![[User Report] Measurement of Immune Cell Metabolic State and Optimization of Culture Environment (Dr. Toshihisa Mikami, Regcell Inc.)](https://image.mono.ipros.com/public/catalog/image/01/3a2/572403/IPROS48483979607369921339.jpeg?w=120&h=170)
![[User Report] Approach to High-Density Culture of Immortalized Megakaryocyte Cell Line (Megakaryon Corporation, Dr.)](https://image.mono.ipros.com/public/catalog/image/01/e9a/572406/IPROS94365243618646491902.jpeg?w=120&h=170)
News about this product（8）
![[On-Demand Webinar Now Streaming]](https://image.mono.ipros.com/public/news/image/1/92f/87731/IPROS20514919479143537008.jpeg?w=280&h=280)
![[On-Demand Webinar Now Streaming]](https://image.mono.ipros.com/public/news/image/1/132/87730/IPROS28878586814574173471.jpeg?w=280&h=280)
Company information
Nova Biomedical Corporation is a bio-medical company headquartered in Boston, USA. Since the development of the ionized calcium sensor in 1978, we have successfully commercialized innovative biosensors and have been providing innovative products that reflect the needs of medical settings and clinical research fields to this day. Our "automated analysis system for cell culture environments" supports research in fields such as "regenerative medicine" and "gene drug discovery." In the fortunate environment known as "Boston Bio Valley," we leverage cutting-edge science and technology to deliver better products to doctors, nurses, technicians, and researchers, continuously challenging ourselves to innovate. We have provided innovative products that reflect the needs of medical settings up to the present day. We will continue to support healthcare professionals and researchers to provide solutions as quickly as possible to patients suffering from difficult diseases. Our company has over 1,000 employees, with sales and service subsidiaries in eight countries and distributors in more than 90 countries. Nova Biomedical's products are being adopted worldwide.